Zoonotic diseases from pet fish are very rare. Rare doesn’t mean zero, something that can be a challenge to message, because there’s a need to balance cost and benefit, and being proactive vs paranoid
Anyway, I have a saltwater fish
Continue Reading Zoonotic infection from a household aquarium
HealthEdge Investment Partners has announced it has sold The Columbus Organization to CareSource.
The Columbus Organization, based in Blue Bell, Pa., provides care/support coordination, professional clinical staffing and quality improvement services for the intellectual/developmental disability (I/DD) or behavioral needs
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: HealthEdge Sells The Columbus Organization
In a preliminary injunction issued on Monday, November 29, 2021, a federal judge in Missouri blocked the implementation and enforcement in 10 states of an interim final rule by the Centers for Medicare & Medicaid Services (CMS) that would require
Continue Reading Federal Judge Blocks CMS Vaccine Mandate for Health Care Workers in 10 States
In an advisory opinion posted November 10, 2021 (AO 21-15), the Office of the Inspector General of the United States Department of Health and Human Services (OIG) appeared to soften a disturbing position that it had taken in
Continue Reading OIG Publishes Favorable Advisory Opinion Related to the Employment Safe Harbor
On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking, exploring whether or not to create new federal regulations governing the practice of telepharmacy. These regulations would govern the receipt of prescriptions and
Continue Reading Is the DEA Poised to Regulate Telepharmacy?
The Food and Drug Administration (FDA) is a consumer protection agency that ensures the safety and efficacy of certain products in the US, such as medical devices, drugs, and prescriptions, tobacco products, cosmetics, food, including animal food, and electronic products
Continue Reading Wait, Wait…Don’t Sell Me! FDA and Other Pre-Market Considerations for Commercial Products
Xeljanz, Rinvoq, and Olumiant Are the Three Janus Kinase (JAK) Inhibitors Getting “Black-Box” Warnings Revisions, Soon
(Posted by Tom Lamb at Drug Injury Watch)
In September 2021 the FDA announced it was requiring revisions to the “Black-Box”
Continue Reading Eli Lilly Attempts to Distance Olumiant From the Ominous JAK Inhibitors Drug Class Safety Issues Flagged by FDA
From our Thought Leaders in Health Law video series: Is your organization ready for the No Surprises Act (NSA)? The law goes into effect January 1, 2022, and contains a new federal ban on surprise billing as well as new
Continue Reading Video: Getting Ready for the No Surprises Act – Thought Leaders in Health Law
Surprise! This morning a federal court in Missouri has ordered the Centers for Medicare & Medicaid Services (CMS) not to enforce the vaccine mandate in these states: Alaska, Arkansas, Iowa, Kansas, Missouri, Nebraska, New Hampshire, North Dakota, South Dakota, and
Continue Reading CMS Interim Final Rule Enjoined
This November, the NHTSA put the auto industry on notice. The U.S. National Highway Traffic Safety Administration (NHTSA) Whistleblower Program has issued its first ever whistleblower award. Whistleblower Kim Gwang-ho received $24.3 million for providing information about Hyundai and
Continue Reading NHTSA Whistleblower Program Issues First Award
